These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 25680936)

  • 1. The value of urodynamic tools to guide patient selection in sacral neuromodulation.
    Drossaerts J; Rademakers K; van Koeveringe G; Van Kerrebroeck P
    World J Urol; 2015 Nov; 33(11):1889-95. PubMed ID: 25680936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Value of Ambulatory Urodynamics in the Evaluation of Treatment Effect of Sacral Neuromodulation.
    Drossaerts J; Rademakers KLJ; Rahnama'i SM; Marcelissen T; Van Kerrebroeck P; van Koeveringe G
    Urol Int; 2019; 102(3):299-305. PubMed ID: 30612126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
    Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
    Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effect of sacral neuromodulation for treatment of detrusor overactivity on urodynamic parameters.
    Groenendijk IM; Groen J; Scheepe JR; Blok BFM
    Neurourol Urodyn; 2020 Feb; 39(2):695-701. PubMed ID: 31804759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral Nerve Stimulation for Pediatric Lower Urinary Tract Dysfunction: Development of a Standardized Pathway with Objective Urodynamic Outcomes.
    Schober MS; Sulkowski JP; Lu PL; Minneci PC; Deans KJ; Teich S; Alpert SA
    J Urol; 2015 Dec; 194(6):1721-6. PubMed ID: 26141849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence.
    Groenendijk PM; Lycklama à Nyeholt AA; Heesakkers JP; van Kerrebroeck PE; Hassouna MM; Gajewski JB; Cappellano F; Siegel SW; Fall M; Dijkema HE; Jonas U; van den Hombergh U;
    BJU Int; 2008 Feb; 101(3):325-9. PubMed ID: 18070199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Duration of Complaints on Successful Outcome of Sacral Neuromodulation.
    Jairam R; Drossaerts J; van Koeveringe G; van Kerrebroeck P
    Urol Int; 2017; 99(1):51-55. PubMed ID: 28478446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for depression and anxiety in patients with storage or voiding dysfunction: A retrospective cohort study predicting outcome of sacral neuromodulation.
    Drossaerts J; Vrijens D; Leue C; Schilders I; Van Kerrebroeck P; van Koeveringe G
    Neurourol Urodyn; 2016 Nov; 35(8):1011-1016. PubMed ID: 26351817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
    Parnell BA; Howard JF; Geller EJ
    Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
    Chen G; Liao L; Wang Y; Ying X
    Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sacral neuromodulation for neurogenic non-obstructive urinary retention in incomplete spinal cord patients: a ten-year follow-up single-centre experience.
    Lombardi G; Musco S; Celso M; Del Corso F; Del Popolo G
    Spinal Cord; 2014 Mar; 52(3):241-5. PubMed ID: 24394604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
    Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
    J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction.
    Peeters K; Sahai A; De Ridder D; Van Der Aa F
    BJU Int; 2014 May; 113(5):789-94. PubMed ID: 24238278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction.
    Daniels DH; Powell CR; Braasch MR; Kreder KJ
    Neurourol Urodyn; 2010 Apr; 29(4):578-81. PubMed ID: 19760757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment.
    Marcelissen TA; Leong RK; Nieman FH; van Lankveld JJ; van Kerrebroeck PE; de Wachter SG
    BJU Int; 2011 Dec; 108(11):1834-8. PubMed ID: 21810157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of sacral neuromodulation treatment success in men with impaired bladder emptying-time for a new diagnostic approach.
    Rademakers KL; Drossaerts JM; van Kerrebroeck PE; Oelke M; van Koeveringe GA
    Neurourol Urodyn; 2017 Mar; 36(3):808-810. PubMed ID: 27062496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the duration of assessment of stage-1 sacral neuromodulation in nonobstructive chronic urinary retention.
    Elneil S; Abtahi B; Helal M; Digesu A; Gonzales G
    Neuromodulation; 2014 Jan; 17(1):66-70; discussion 70-1. PubMed ID: 23601054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambulatory urodynamic studies (UDS) in children using a Bluetooth-enabled device.
    Deshpande AV; Craig JC; Caldwell PH; Smith GH
    BJU Int; 2012 Dec; 110 Suppl 4():38-45. PubMed ID: 23194124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.